A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics.

Abstract

Cystic fibrosis (CF) is a life-limiting hereditary disorder that results in aberrant mucosa in the lungs and digestive tract, chronic respiratory infections, chronic inflammation, and the need for repeated antibiotic treatments. Probiotics have been demonstrated to improve the quality of life of CF patients. We investigated the distribution of gut… (More)
DOI: 10.3390/nu9121342

Cite this paper

@article{Vernocchi2017AMA, title={A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics.}, author={Pamela Vernocchi and Federica Del Chierico and Andrea Quagliariello and Danilo Ercolini and Vincenzina Lucidi and Lorenza Putignani}, journal={Nutrients}, year={2017}, volume={9 12} }